Current Funding

1. U01 AI184289-01 "Sex-dependent Impairment of Nitric Oxide Signaling and Mitochondrial
   Metabolism in Radiation-Induced Cardio-Pulmonary Dysfunction"
2. 1 R21 CA270742-01A1 “Redox manipulation of iron to improve glioblastoma therapy: A phase 1 trial
3. Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy, Project Number: P01 CA217797

Past Funding

1. Cancer Center Support Grant (CCSG), Project Number: P30 CA086862
2. Redox Regulation of Immunological Responses During Cancer Therapy Using Novel Redox Active Molecule Approaches that Both Enhance Anti-Tumor Immune Responses and Limit Normal Tissue Injury
3. University of Iowa Public-Private Partnership (P3) 
4. Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC), Project Number: GTI-4711-101, Galera Therapeutics, Inc.
5. A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer, Galera Therapeutics, Inc.